Titan Pharmaceuticals TTNP

$ 3.63 -4.72%

Quarterly report 2024-Q2
added 08-15-2024

Titan Pharmaceuticals Total Shareholders Equity 2011-2024 | TTNP

Annual Total Shareholders Equity Titan Pharmaceuticals

2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
6.64 M	1.36 M	5.14 M	3.53 M	1.43 M	6.83 M	857 K	13.2 M	6.99 M	8.61 M	5.76 M	-23.1 M	-20.1 M

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
13.2 M	-23.1 M	1.32 M

Quarterly Total Shareholders Equity Titan Pharmaceuticals

2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
3.99 M	6.09 M	6.64 M	8.13 M	-1.03 M	-312 K	1.36 M	3.55 M	5.67 M	7.88 M	5.14 M	7.5 M	8.75 M	9.98 M	3.53 M	3.53 M	3.53 M	3.53 M	1.43 M	1.43 M	1.43 M	1.43 M	6.83 M	6.83 M	6.83 M	6.83 M	857 K	857 K	857 K	857 K	13.2 M	13.2 M	13.2 M	13.2 M	6.99 M	6.99 M	6.99 M	6.99 M	8.61 M	8.61 M	8.61 M	8.61 M	5.76 M	5.76 M	5.76 M	5.76 M	-23.1 M	-23.1 M	-23.1 M	-23.1 M	-20.1 M	-20.1 M	-20.1 M	-20.1 M

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
13.2 M	-23.1 M	1.65 M